Back

Clinical Deep Data Accumulation System (CLIDAS) reveals a "Lipid paradox" of hypertriglyceridemia in Japanese patients.

2 September 2024 (13:00 - 13:40)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factors among different populations Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Shunsuke Katsuki

Kyushu University Hospital, Fukuoka (Japan)

5 More presentations in this session

Presentation thumbnail
The associations of triglyceride glucose and its derived indexes with 10-year cardiovascular disease risk in a Chinese community-based population
Doctor F. Fan (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Lipid changes across menopause status point to increased cardiovascular risk
Doctor S. Moreno (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Body mass index as a contributor to the accumulation of lipidic plaque materials in statin-treated type 2 diabetic patients with coronary artery disease: sub-analysis from the OPTIMAL randomized study
Mr A. Salib (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Patient reported outcomes, control of hypertension and dyslipidemia: results of two epidemiological studies in Romania, conducted during pandemia (Snapshot-1) and post-pandemic (Snapshot-2)
Doctor A. Ciobanu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Trajectories of lipid profile during adolescence and risk of subclinical atherosclerosis in early adulthood: a two-decade population-based study
Doctor F. Esmaeili (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factors among different populations

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Triglyceride levels show a U-shaped association with cardiovascular events: insights from the CLIDAS database on the lipid paradox among Japanese patients with acute coronary syndrome
thumbnail
Congress Presentation
Treatment of dyslipidaemia in cardiometabolic syndrome: how far should you go?
thumbnail
Congress Session
Late-Breaking Clinical Science: lipids and cardiovascular risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources